Experiment 375301

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE

Compounds isolated

BRYOSTATIN 1

Alerts

SEE ARTICLE FOR OTHER TEST RESULTS.A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationMOHAMMAD,RM: VARTERASIAN,ML: ALMATCHY,VP: HANNOUDI,GN: PETTIT,GR: AL-KATIB,A:. (1998). SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTE LEUKEMIA XENOGRAFTS WITH COMBINATION BIOLOGICAL AGENTS AURISTATIN PE AND BRYOSTATIN 1.. 4(5)
Amount utilized
Compound isolated
DiseaseANIMALS WERE TREATED IN COMBINATION WITH AURISTATIN PE.
Dose amount75.0 MCG
Number2
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE
GenderMALE